- $109.00bn
- $107.88bn
- $12.26bn
- 61
- 43
- 92
- 72
Annual cashflow statement for CME, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | 10-K | 10-K | 10-K | 10-K | |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 2,637 | 2,691 | 3,226 | 3,526 | — |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -497 | 79.5 | 10.8 | 85.9 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -157 | -53.9 | -60.8 | -192 | — |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2,402 | 3,056 | 3,454 | 3,691 | — |
| Capital Expenditures | -127 | -89.7 | -76.4 | -94 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 186 | -400 | 97.3 | 11.4 | — |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 58.4 | -490 | 20.9 | -82.6 | — |
| Financing Cash Flow Items | 71,133 | -22,733 | -45,087 | 8,661 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 69,909 | -25,382 | -48,339 | 5,077 | — |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 72,370 | -22,816 | -44,865 | 8,684 | — |